Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Rocket Pharmaceuticals In...

    NASDAQ: RCKT · Real-Time Price · USD
    2.71
    -0.17 (-5.90%)
    At close: Jun 17, 2025, 3:59 PM
    2.73
    0.55%
    After-hours: Jun 17, 2025, 07:36 PM EDT

    Rocket Pharmaceuticals Statistics

    Share Statistics

    Rocket Pharmaceuticals has 107.74M shares outstanding. The number of shares has increased by 17.46% in one year.

    Shares Outstanding

    n/a
    		 107.74M

    Shares Change (YoY)

    n/a
    		 17.46%

    Shares Change (QoQ)

    n/a
    		 0.28%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 99.77M

    Failed to Deliver (FTD) Shares

    n/a
    		 485

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 12.65M, so 11.74% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 12.65M

    Short % of Shares Out

    n/a
    		 11.74%

    Short % of Float

    n/a
    		 22.89%

    Short Ratio (days to cover)

    n/a
    		 1.19

    Valuation Ratios

    The PE ratio is -4.61 and the forward PE ratio is -1.75. Rocket Pharmaceuticals's PEG ratio is 0.71.

    PE Ratio

    n/a
    		 -4.61

    Forward PE

    n/a
    		 -1.75

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 1.2

    PB Ratio

    n/a
    		 2.57

    P/FCF Ratio

    n/a
    		 -5.53

    PEG Ratio

    n/a
    		 0.71
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Rocket Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 9.3, with a Debt / Equity ratio of 0.06.

    Current Ratio

    n/a
    		 9.3

    Quick Ratio

    n/a
    		 9.3

    Debt / Equity

    n/a
    		 0.06

    Debt / EBITDA

    n/a
    		 -0.09

    Debt / FCF

    n/a
    		 -0.12

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-865,371.24

    Employee Count

    n/a
    		 299

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -86.42% in the last 52 weeks. The beta is 0.68, so Rocket Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.68

    52-Week Price Change

    n/a
    		 -86.42%

    50-Day Moving Average

    n/a
    		 5.45

    200-Day Moving Average

    n/a
    		 11.43

    Relative Strength Index (RSI)

    n/a
    		 32.62

    Average Volume (20 Days)

    n/a
    		 4,807,623

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -273.2M

    Net Income

    n/a
    		 -258.75M

    EBITDA

    n/a
    		 -273.2M

    EBIT

    n/a
    		 -260.63M

    Earnings Per Share (EPS)

    n/a
    		 -2.73
    Full Income Statement

    Balance Sheet

    The company has 163.63M in cash and 25.5M in debt, giving a net cash position of 138.14M.

    Cash & Cash Equivalents

    n/a
    		 163.63M

    Total Debt

    n/a
    		 25.5M

    Net Cash

    n/a
    		 138.14M

    Retained Earnings

    n/a
    		 -1.22B

    Total Assets

    n/a
    		 471.07M

    Working Capital

    n/a
    		 289.18M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -209.72M and capital expenditures -5.86M, giving a free cash flow of -215.59M.

    Operating Cash Flow

    n/a
    		 -209.72M

    Capital Expenditures

    n/a
    		 -5.86M

    Free Cash Flow

    n/a
    		 -215.59M

    FCF Per Share

    n/a
    		 -2.27
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    RCKT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for RCKT is $15, which is 420.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $15

    Price Target Difference

    n/a
    		 420.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 12
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jan 5, 2018. It was a backward split with a ratio of 1:4.

    Last Split Date

    n/a
    		 Jan 5, 2018

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:4

    Scores

    Altman Z-Score

    n/a
    		 -1.99

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist